Showing results (291-300 of 321) with videos related to
Sort By:
Pageof 33
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patientsM Davidson, M F Losonczy, R C Mohs, et al.Neurology|February 20, 1999
CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's diseaseS C Samuels, J M Silverman, D B Marin, et al.Schizophrenia Research|May 1, 1994
Cortical cholinergic markers in schizophreniaV Haroutunian, M Davidson, P D Kanof, et al.Journal of the American Geriatrics Society|November 15, 1997
Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptomsD B Marin, C R Green, J Schmeidler, et al.The American Journal of Psychiatry|September 1, 1991
Plasma homovanillic acid in schizotypal personality disorderL J Siever, F Amin, E F Coccaro, et al.The American Journal of Psychiatry|July 1, 1987
Characteristics of very poor outcome schizophreniaR S Keefe, R C Mohs, M F Losonczy, et al.Archives of General Psychiatry|July 1, 1990
Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patientsL J Siever, J M Silverman, T B Horvath, et al.Journal of Medicinal Chemistry|August 1, 1989
9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeuticsG M Shutske, F A Pierrat, K J Kapples, et al.Journal of Neurochemistry|February 1, 1995
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficitsL M Bierer, V Haroutunian, S Gabriel, et al.Psychiatry Research|July 1, 1994
Performance of nonpsychotic relatives of schizophrenic patients on cognitive testsR S Keefe, J M Silverman, S E Roitman, et al.Pageof 33